Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Acapatamab in metastatic castration-resistant prostate cancer reports safety, tolerability, pharmacokinetics, and preliminary efficacy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Acapatamab (acapatamab)

Snippet

Sponsor: Amgen | Conditions: Metastatic Castration-resistant Prostate Cancer, Prostate Cancer | Phase 1 | Status: TERMINATED